- Home
- ATXS vs VSTM Comparison
ATXS vs VSTM Comparison
Compare ATXS & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATXS | VSTM |
|---|---|---|
| Founded | 2008 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 722.1M | 710.3M |
| IPO Year | 2015 | 2012 |
Fundamental Metrics
Financial Performance| Metric | ATXS | VSTM |
|---|---|---|
| Price | $12.93 | $9.55 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $24.33 | $13.38 |
| AVG Volume (30 Days) | 1.3M | ★ 2.1M |
| Earning Date | 11-12-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $706,000.00 | ★ $13,379,000.00 |
| Revenue This Year | N/A | $183.10 |
| Revenue Next Year | N/A | $271.39 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 33.79 |
| 52 Week Low | $3.56 | $3.46 |
| 52 Week High | $13.29 | $11.25 |
Technical Indicators
Market Signals| Indicator | ATXS | VSTM |
|---|---|---|
| Relative Strength Index (RSI) | 64.63 | 49.05 |
| Support Level | $12.87 | $9.66 |
| Resistance Level | $13.29 | $10.70 |
| Average True Range (ATR) | 0.22 | 0.55 |
| MACD | -0.05 | -0.10 |
| Stochastic Oscillator | 63.68 | 25.13 |
Price Performance
Historical ComparisonAbout ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.